Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial

Authors: Kevin Fitzgerald, Maria Frank-Kamenetsky, Svetlana Shulga‐Morskaya, Abigail Liebow, Brian R. Bettencourt, Jessica E. Sutherland, Renta Hutabarat, Valerie A. Clausen, Verena Karsten, Jeffrey Cehelsky, Saraswathy V. Nochur, Victor Kotelianski, Jay D. Horton, Timothy Mant, Joseph Chiesa, James M. Ritter, Malathy Munisamy, Akshay Vaishnaw, Jared Gollob, Amy Simon - The Lancet 2013 cited by 574